Screen-detected Coeliac Disease, a Population Based Study
1 other identifier
interventional
172
1 country
1
Brief Summary
The purpose of this study is to determine the prevalence of previously undiagnosed coeliac disease based on a health survey from Tromsø, Norway. Moreover, the health impact of undiagnosed coeliac disease will be examined.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Oct 2012
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 26, 2012
CompletedFirst Posted
Study publicly available on registry
September 28, 2012
CompletedStudy Start
First participant enrolled
October 1, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 15, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
April 15, 2015
CompletedMarch 11, 2020
March 1, 2020
2.5 years
September 26, 2012
March 9, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Gastrointestinal symptoms: Gastrointestinal symptoms rating scale (GSRS)
The Gastrointestinal symptoms rating scale (GSRS) is a disease-specific instrument with 15 items combined into five major domains: Reflux, Abdominal pain, Indigestion, Diarrhoea and Constipation. The scale assesses symptom severity using a seven-grade Likert scale, ranging from 1 (no discomfort at all) to 7 (very severe discomfort). A lower score indicates less symptoms. GSRS is obtained at first visit and at follow-up (\>one year) to evaluate change in one of the five domain scores or total score (primary outcome)
7 days
Secondary Outcomes (3)
Quality of life score: Psychological General Well-Being Index (PGWBI)
7 days
Self-reported change in abdominal complaints
One year
Self-reported change in energy
One year
Study Arms (1)
Dietary instruction
OTHERGluten-free diet
Interventions
Eligibility Criteria
You may qualify if:
- Increased level of serological markers (Transglutaminase 2 or Deamidated Gliadin) and biopsy verified coeliac disease
You may not qualify if:
- Previously diagnosed coeliac disease
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University hospital of North Norway
Tromsø, 9038, Norway
Related Publications (1)
Kvamme JM, Sorbye S, Florholmen J, Halstensen TS. Population-based screening for celiac disease reveals that the majority of patients are undiagnosed and improve on a gluten-free diet. Sci Rep. 2022 Jul 25;12(1):12647. doi: 10.1038/s41598-022-16705-2.
PMID: 35879335DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jan- M Kvamme, MD PhD
University of Tromso
- STUDY CHAIR
Trond Halstensen, MD PhD
University of Oslo
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 26, 2012
First Posted
September 28, 2012
Study Start
October 1, 2012
Primary Completion
April 15, 2015
Study Completion
April 15, 2015
Last Updated
March 11, 2020
Record last verified: 2020-03